Study of Reiter's Syndrome, with Special Emphasis on Yersinia Enterocolitica

Immunological Reviews

Volumn 86, Issue 1, 1985, Pages 27-46

  Yu, David Tak Yan ^a   Ogasawara, Minoru ^a   Hill, Jeri L ^a   Kono, Dwight H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; HLA ANTIGEN; HLA B27 ANTIGEN; OUTER MEMBRANE PROTEIN;

ANIMAL; ANKYLOSING SPONDYLITIS; ANTIBODY SPECIFICITY; ARTHRITIS; ARTICLE; BACTERIAL INFECTION; HUMAN; IMMUNOLOGY; MOLECULAR WEIGHT; PATHOGENICITY; RABBIT; REITER SYNDROME; SEROTYPING; T LYMPHOCYTE; YERSINIA ENTEROCOLITICA; CROSS REACTION; ETIOLOGY; HEREDITY; IMMUNE RESPONSE; JOINT; PRIORITY JOURNAL; SMALL INTESTINE;

ANIMAL; ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; ANTIGENS, BACTERIAL; ARTHRITIS; BACTERIAL OUTER MEMBRANE PROTEINS; HLA ANTIGENS; HLA-B27 ANTIGEN; HUMAN; MOLECULAR WEIGHT; RABBITS; REITER DISEASE; SEROTYPING; SPONDYLITIS, ANKYLOSING; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES; YERSINIA ENTEROCOLITICA; YERSINIA INFECTIONS;

EID: 0021846009     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1985.tb01136.x     Document Type: Article

References (68)

1. HL‐A 27 in reactive arthritis: a study of yersinia arthritis and Reiter's disease
2. Human yersiniosis in Finland, I. Bacteriology and serology
3. Human yersiniosis in Finland. II. Clinical features
4. The distribution of a specific HLA‐B27 associated cell surface component on the tissues of patients with ankytosing spondylitis
5. Ankylosing spondylitis, HLA‐B‐27 and Klebsiella. II. Cross‐reactivity studies with human tissue typing sera
6. Klebsiella related antigens in Ankylosing Spondylitis
7. Major heat‐modifiable outer membrane protein in gram negative bacteria: comparison with the OmpA protein of Escherichia coli
8. Yersinia enterocolitica isolates from humans in California 1968–1975
9. Temperature‐inducible outer membrane protein of Yersinia pseudotuberculosis and Yersinia enterocolitica associated with the virulence plasmid
10. Yersinia enterocolitica: a panoramic view of a charismatic organism
11. In vitro T lymphocyte proliferative response to Yersinia enterocolitica in Reiter's syndrome. Lack of response in other HLA‐B27 positive individuals
12. Spondyloarthropathies: an overview
13. Immune function in ankylosing spondylitis and their relatives: influence of disease and HLA‐B27
14. Introduction to part II. Principal evidence associating rheumatic diseases with microbial infection
15. Sequential studies in ankylosing spondylitis: association of Klebsiella pneumoniae and active disease
16. Circulating immune complexes in seronegative spondyloarthropathics
17. Lymphocyte abnormalities in ankylosing spondylitis
18. Cell‐mediated immune responses of synovial mononuclear cells to sexually transmitted, enteric and mumps antigens in patients with Reiter's syndrome, rheumatoid arthritis and ankylosing spondylitis
19. Persistence of IgM, IgG and IgA antibodies to Yersinia in Yersinia arthritis
20. Measurement of immunoglobulin M. immunoglobulin G. and immunoglobulin A antibodies against Yersinia enterocolitica by enzyme‐linked immunosorbent assay: comparison of lipopolysaccharide and whole bacterium as antigen
21. Monoclonal antibody (B27M2) subdividing HLA‐B27
22. Outer membrane of gram‐negative bacteria. XIX. isolation from Pseudomonas aeruginosa PA01 and use in reconstitution and definition of the permeability barrier
23. Antibody response of infected mouse to outer membrane proteins of Pseudomonas aeruginosa
24. A preliminary analysis of the membrane proteins of arthritis‐causing Yersinia
25. Antigenic cross‐reactivity of major outer membrane proteins in Enterobacteriaceae
26. Biochemical and serological characterization of Yersinia enterocolitica
27. Virulence and phenotypic characterization of Yersinia enterocolitica isolated from humans in the United Stales
28. Reiter's syndrome and reactive arthritis in perspective
29. Ankylosing spondylitis, a disease in search of microbes
30. Antibodies against Yersinia enterocolitica in patients with Reiter's syndrome
31. Structural requirements for antigenicity for arthritogenicity of peptidoglycan for Staphylococcus aureus and Lactobacillus planatarus and analogous compounds
32. Ye‐1, a monoclonal antibody that cross‐reacts with HLA‐B27 lymphoblastoid cell lines and arthritis‐causing bacteria
33. An animal model to study serum immunoglobulin response to infection by Yersinia enterocolitica
34. Absence of lymphotoxic antibodies in patients with Yersinia‐induced arthritis, Reiter's syndrome and ankylosing spondylitis
35. Variation in surface protein composition associated with virulence properties in opacity types of Neisseria gonorrhoea
36. Depressed lymphocyte transformation by yersinia and Escherichia coli in yersinia arthritis
37. FoUowup study on patients with Reiter's disease and reactive arthritis with special reference to HLA‐B27
38. A study of the specificity of the direct binding between bacteria and HLA antigens
39. Plasmid‐mediated and temperature‐regulated surface properties of Yersinia enterocolitica
40. Effects of heating in dodecyl sulfate solution on the confirmation and electrophoretic mobility of isolated majour outer membrane proteins from Escherichia coli K12
41. Outer membrane of Salmonella. Isolation of protein complex that produces transmembrane channels
42. Subunit structure of functional porin oligomers that form permeability channels in the outer membrane of Escherichia coli
43. The outer membrane of gram‐negative bacteria
44. The genus‐specific antigen of Chlamydia: Resemblance to the lipopolysaccharide of enteric bacteria
45. A heat ‐ modifiable outer membrane protein carries an antigen specific for the species Yersinia enterocolitica and Yersinia pseudotuberculosis
46. A Yersinia enterocolitica 0:3 lipopolysaccharide‐ specific monoclonal antibody reacts more strongly with bacteria cultured at room temperature than those cultured at 37 °C
47. Analysis of rabbit antisera against three different bacteria which could induce reactive arthritis using ELISA, immunoprecipitation and Western Blot
48. Antibodies to peptidoglycan in patients with spondyloarthritis: a clue to disease aetiology
49. Characterization of common virulence plasmids in Yersinia species and the role in the expression of outer membrane proteins
50. Molecular characterization of a heat‐modifiable protein from the outer membrane of Escherichia coli
51. Chemotaxis in yersinia arthritis. In vitro stimulation of neutrophil migration by HLA‐B27 positive and negative sera
52. Solubilization of the cytoplasmic membrane of Escherichia coli by Triton X‐100
53. Outer membrane proteins of Escherichia. I. Effect of preparative conditions on the migration of proteins in polyacrylamide gels
54. Evidence for a specific B27–associated cell surface marker on lymphocytes of patients with ankylosing spondylitis
55. Reiter's syndrome
56. Reiter's syndrome following epidemic Shigellosis
57. Expression of antigens encoded by the virulence plasmid of Yersinia enterocolitica under different growth conditions
58. Immunochemical characterization of Klebsiella antigens which specifically modify HLA‐B27 associated cell‐surface component
59. An outbreak of Yersinia pseudotuberculosis infection
60. Electrophoretic transfer of proteins from polyacrylamide gel to nitrocellulose sheet: procedure and some application
61. HLA‐B27 and the immune response to enterobacterial antigens in ankylosing spondylitis
62. HLA B27: speculation on the nature of its involvement in ankylosing spondylitis
63. Identification of HLA‐B27M1 and M2 cross‐reactive antigens in Klebsiella, Shigella and Yersinia
64. Peripheral blood T lymphocyte subpopulations in HLA‐B27 related rheumatic diseases: ankylosing spondylitis and reactive synovitis
65. Antigens of Yersinia enterocolitica
66. Ankylosing spondylitis, HLA‐B27 and Klebsiella. I. Cross‐reactivity studies with rabbit antisera
67. Reiter's syndrome: evaluation of preliminary criteria for definite disease
68. Type‐specific antigens of group A Neisseria meningitidis lipopolysaccharide and heat‐modifiable outer membrane proteins